© 2020 – 2023 AEA3 WEB | AEAƎ United Kingdom News
AEA3 WEB | AEAƎ United Kingdom News
News

NHS cancer patients denied life-saving drugs due to Brexit costs, report finds

Exclusive: Britons found to have ‘lost out’ while rest of Europe benefits from golden age of research and treatments

  • ‘Children with cancer cannot wait’: the human cost of clinical trial delays after Brexit

British cancer patients are being denied life-saving drugs and trials of revolutionary treatments are being derailed by the red tape and extra costs brought on by Brexit, a damning report warns.

Soaring numbers are being diagnosed with the disease amid a growing and ageing population, improved diagnosis initiatives and wider public awareness – making global collaborations to find new medicines essential.

Continue reading…

Related posts

Leeds hospital evacuated after suspicious package found

AEA3

Lions led by donkeys: Cummings uses broad strokes to portray colleagues

AEA3

No-deal Brexit would make Britons less safe, ex-national security adviser says

AEA3

Pin It on Pinterest

Share This